Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Envoy Medical Inc. (COCHW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/05/2025: COCHW (1-star) is a SELL. SELL since 3 days. Simulated Profits (-33.33%). Updated daily EoD!
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -80% | Avg. Invested days 21 | Today’s Advisory SELL |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/05/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 2.27 | 52 Weeks Range 0.03 - 0.10 | Updated Date 06/28/2025 |
52 Weeks Range 0.03 - 0.10 | Updated Date 06/28/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -11102.17% |
Management Effectiveness
Return on Assets (TTM) -129.07% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 10658404 |
Shares Outstanding - | Shares Floating 10658404 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Envoy Medical Inc.
Company Overview
History and Background
Envoy Medical Inc. focuses on developing innovative implantable medical devices for hearing loss. Formerly known as Sound ID, they rebranded to Envoy Medical. The company has focused on fully implanted hearing devices, requiring significant development and regulatory approval efforts.
Core Business Areas
- Fully Implanted Hearing Aids: Development, manufacturing, and commercialization of the Esteem fully implanted hearing aid, their primary product. It aims to restore natural hearing without the need for external components.
Leadership and Structure
Details about the leadership team and organizational structure are generally available on their investor relations page and in SEC filings. Public information about their leadership roles is available on their website and business press.
Top Products and Market Share
Key Offerings
- Esteem Fully Implanted Hearing Aid: Envoy Medical's main product, the Esteem, is a fully implanted hearing aid designed to provide natural hearing. Market share information is not publicly available, but competitors include traditional hearing aid manufacturers such as Sonova (SONX.SW), Demant (DEMANT.CO), and GN Store Nord (GN.CO), as well as companies developing other implantable solutions.
Market Dynamics
Industry Overview
The hearing aid market is characterized by an aging population, technological advancements in digital signal processing and miniaturization, and increasing awareness of hearing loss. Implantable devices represent a smaller but growing segment, offering advantages in terms of aesthetics, convenience, and sound quality.
Positioning
Envoy Medical positions itself as an innovator in the implantable hearing aid market, offering a unique fully implanted solution. Competitive advantages include the potential for better sound quality and reduced stigma compared to traditional hearing aids.
Total Addressable Market (TAM)
The global hearing aids market is projected to reach tens of billions USD annually. Envoy Medical's positioning relative to this TAM depends on their ability to gain regulatory approvals, scale up manufacturing, and secure reimbursement coverage.
Upturn SWOT Analysis
Strengths
- Innovative fully implanted technology
- Potential for superior sound quality
- Reduced stigma compared to traditional hearing aids
- Experienced management team
Weaknesses
- Limited product portfolio
- High development and manufacturing costs
- Reliance on regulatory approvals
- Limited financial resources
Opportunities
- Growing demand for hearing aids
- Increasing awareness of implantable solutions
- Potential for partnerships with established hearing aid manufacturers
- Expansion into new markets
Threats
- Competition from established hearing aid manufacturers
- Technological advancements in traditional hearing aids
- Regulatory hurdles
- Economic downturn
Competitors and Market Share
Key Competitors
- Sonova (SONX.SW)
- Demant (DEMANT.CO)
- GN Store Nord (GN.CO)
Competitive Landscape
Envoy Medical faces competition from established hearing aid manufacturers with extensive distribution networks and technological advantages. Their competitive advantage lies in their fully implanted technology.
Growth Trajectory and Initiatives
Historical Growth: Historical growth for Envoy can be observed after the company has gone public.
Future Projections: Future projections depend on analyst estimates, regulatory approvals, and successful commercialization.
Recent Initiatives: Recent initiatives usually include clinical trials, regulatory submissions, and fundraising efforts.
Summary
Envoy Medical is a development-stage company with an innovative fully implanted hearing aid technology. Its success depends on regulatory approvals, manufacturing scalability, and commercialization efforts. Facing competition from established players, its unique product offers potential for significant market share. Maintaining a strong balance sheet and successful fundraising will be crucial for its growth trajectory.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Industry Reports
- Analyst Reports
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Market share figures are estimates and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Envoy Medical Inc.
Exchange NASDAQ | Headquaters White Bear Lake, MN, United States | ||
IPO Launch date 2021-04-23 | CEO & Director Mr. Brent T. Lucas Esq. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 42 | Website https://www.envoymedical.com |
Full time employees 42 | Website https://www.envoymedical.com | ||
Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.